Macquarie Group’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,167
Closed -$41K 1972
2022
Q3
$41K Hold
14,167
﹤0.01% 1999
2022
Q2
$49K Hold
14,167
﹤0.01% 2062
2022
Q1
$67 Buy
+14,167
New +$69.3K ﹤0.01% 2052
2019
Q1
Sell
-7,400
Closed -$13K 1887
2018
Q4
$13K Buy
+7,400
New +$41K ﹤0.01% 1879
2018
Q3
Sell
-73,500
Closed -$470K 2222
2018
Q2
$470K Buy
73,500
+9,800
+15% +$69.8K ﹤0.01% 1380
2018
Q1
$444K Sell
63,700
-2,413
-4% -$28.1K ﹤0.01% 1426
2017
Q4
$834K Sell
66,113
-1,681,996
-96% -$20.5M ﹤0.01% 1290
2017
Q3
$20.8M Sell
1,748,109
-1,515,310
-46% -$22.5M 0.04% 447
2017
Q2
$48.9M Sell
3,263,419
-281,100
-8% -$3.75M 0.09% 197
2017
Q1
$33.8M Buy
3,544,519
+618,222
+21% +$5.22M 0.06% 288
2016
Q4
$25.9M Buy
2,926,297
+518,775
+22% +$4.66M 0.05% 360
2016
Q3
$20.7M Buy
2,407,522
+2,360,022
+4,968% +$18.7M 0.04% 406
2016
Q2
$380K Buy
47,500
+4,771
+11% +$37.1K ﹤0.01% 1411
2016
Q1
$373K Buy
+42,729
New +$355K ﹤0.01% 1275

Other funds holding MDXG

Macquarie Group's MDXG Position: Q4 2022 in Review

Macquarie Group sold out of MiMedx Group (MDXG) in Q4 2022, closing a stake of 14,167 shares — an estimated $41K sold.

Macquarie Group first reported a position in MDXG in Q1 2016 and held it in 14 quarters. The position peaked at $48.9M in Q2 2017. 152 funds tracked by Wall St. Rank hold MDXG as of Q4 2022.

  • Macquarie Group reported no remaining MiMedx Group position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 14,167 MiMedx Group shares in Q4 2022, an estimated $41K.
  • Macquarie Group first reported a position in MiMedx Group in Q1 2016 and held it in 14 quarters.
  • Macquarie Group's MiMedx Group position peaked at $48.9M in Q2 2017.
  • 152 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.